Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (201)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (16)
2023 (30)
2022 (102)
2021 (32)
2020 (52)
2019 (59)
2018 (35)
2017 (51)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (10)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Results for "[search-keyword]"

Search

Sponsor content

492 result(s) found, displaying 241 to 250

TERRY WHITE CHEMISTS TRAMADOL SR tramadol hydrochloride 200 mg oral tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
SENIERE betahistine dihydrochloride 16mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR FBM famciclovir 250 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TRAMADOL AN SR tramadol hydrochloride 200 mg oral modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMISOLAN 200 amisulpride 200 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMISOLAN 400 amisulpride 400 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMISOLAN 100 amisulpride 100 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ERYTHROMYCIN HHH erythromycin (as lactobionate) 1 g powder for injection vial (290145)

24 May 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERYTHROMYCIN HHH erythromycin (as lactobionate) 1 g powder for injection vial.
TIBOLONE LUPIN tibolone 2.5 mg tablet blister pack (286595)

4 April 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TIBOLONE LUPIN tibolone 2.5 mg tablet blister pack.
TIBOLONE SANDOZ tibolone 2.5 mg tablet blister pack (286596)

4 April 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TIBOLONE SANDOZ tibolone 2.5 mg tablet blister pack.

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.